Sullivan SE, Liao M, Smith RV, et al. Candidate-based screening via gene modulation in human neurons and astrocytes implicates FERMT2 in Aβ and TAU proteostasis. Hum Mol Genet. 2019;28(5):718-735. doi:10.1093/hmg/ddy376.

Hazelbaker DZ, Beccard A, Bara AM, et al. A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease. Stem Cell Reports. 2017;9(4):1315-1327. doi:10.1016/j.stemcr.2017.09.006.

Burguière E, Monteiro P, Feng G, Graybiel AM. Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors. Science. 2013;340(6137):1243-6. doi:10.1126/science.1232380.

Scott DA, Zhang F. Implications of human genetic variation in CRISPR-based therapeutic genome editing. Nat Med. 2017;23(9):1095-1101. doi:10.1038/nm.4377.

Najm FJ, Strand C, Donovan KF, et al. Orthologous CRISPR-Cas9 enzymes for combinatorial genetic screens. Nat Biotechnol. 2018;36(2):179-189. doi:10.1038/nbt.4048.

Gebre M, Nomburg JL, Gewurz BE. CRISPR-Cas9 Genetic Analysis of Virus-Host Interactions. Viruses. 2018;10(2). doi:10.3390/v10020055.

Pacheco AR, Lazarus JE, Sit B, et al. CRISPR Screen Reveals that EHEC’s T3SS and Shiga Toxin Rely on Shared Host Factors for Infection. mBio. 2018;9(3). doi:10.1128/mBio.01003-18.

Li W, Köster J, Xu H, et al. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biol. 2015;16:281. doi:10.1186/s13059-015-0843-6.

Lu TK, Chandrasegaran S, Hodak H. The Era of Synthetic Biology and Genome Engineering: Where No Man Has Gone Before. J Mol Biol. 2016;428(5 Pt B):835-6. doi:10.1016/j.jmb.2016.01.025.

Woods IG, Schier AF. Targeted mutagenesis in zebrafish. Nat Biotechnol. 2008;26(6):650-1. doi:10.1038/nbt0608-650.